Sang Mi Chae

Title: Innovations by Sang Mi Chae

Introduction

Sang Mi Chae is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diabetic complications and mental health conditions. With a total of 5 patents to his name, his work continues to impact the medical community.

Latest Patents

Sang Mi Chae's latest patents include innovative methods for treating diabetic complications using carbamoyloxy arylalkanoyl arylpiperazine compounds. One notable patent describes a method for treating pain, anxiety, or depression with a novel carbamoyloxy arylalkanoyl arylpiperazine derivative. This compound exhibits unique racemic or enantiomeric characteristics and is accompanied by pharmaceutically available salts or hydrates. Additionally, he has developed a pharmaceutical composition that effectively addresses pain, anxiety, or depression in mammals.

Career Highlights

Sang Mi Chae is currently associated with Sk Biopharmaceuticals Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential to improve treatment options for various health conditions.

Collaborations

Sang Mi Chae collaborates with notable colleagues, including Hong Sik Moon and Han Ju Yi, who contribute to his research endeavors. Their combined expertise enhances the innovative approaches taken in their projects.

Conclusion

Sang Mi Chae's contributions to the field of pharmaceuticals through his patents and collaborations highlight his commitment to advancing medical treatments. His work continues to pave the way for new therapeutic options that can significantly improve patient outcomes.